Equities

Solid Biosciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SLDB:NSQ

Solid Biosciences Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)6.19
  • Today's Change0.11 / 1.81%
  • Shares traded1.00
  • 1 Year change+57.11%
  • Beta2.6435
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, Solid Biosciences Inc increased its cash reserves by 8.36%, or 6.34m. Cash Flow from Financing totalled 122.44m or -- of revenues. In addition the company used 100.01m for operations while cash used for investing totalled 16.09m.
Cash flow per share-2.22
Price/Cash flow per share--
Book value per share2.80
Tangible book value per share2.80
More ▼

Balance sheet in USDView more

Solid Biosciences Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio6.74
Quick ratio--
Total debt/total equity0.0013
Total debt/total capital0.0013
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.